24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Why Are Fewer U.S. Kids Going to Pediatricians?Severe Deprivation in Childhood Has Lasting Impact on Brain SizeHealth Tip: What Your Child Can do About BullyingWildfires Send Kids to ERs for Breathing ProblemsTV Can Be a Good Influence on Kids' Eating HabitsWould Tighter Swimming Rules at Public Beaches, Lakes and Rivers Save Lives?U.S. Doctors Often Test, Treat Kids UnnecessarilyHealth Tip: Safety Steps if Your Child is Home AloneHealth Tip: Help Your Child Safely Lose WeightAmericans Need to Tackle Youth Obesity: U.S. Task ForceGenes, Family Are Key Predictors of School SuccessKids' 'Microbiome' May Play Key Role in AsthmaA Puppy in Santa's Sack? Probably Not, Say ParentsMore Kids, Teens Landing in ERs After Opioid OverdosesGetting Active Helps Kids' Hearts, Even in the ObeseWhen Does Your Child's Flu Merit an ER Visit?Health Tip: Managing Hearing Loss in ChildrenHealth Tip: Is My Child Too Sick to Go to School?Differences Found in Brains of Kids Born to Depressed ParentsSecondhand Smoke Starts Kids on Path to Heart Disease: StudyHealth Tip: Choosing a PediatricianMany Kids Traveling Overseas Aren't Vaccinated Against MeaslesCould Obesity Alter a Child's Brain Structure?Dramatic Rise in Eye Injuries From BB and Paintball GunsTwo-Thirds of Child Abuse Survivors Do Well as AdultsAHA News: Serious Heart Defects Increase Heart Failure Risk in Early AdulthoodMore U.S. Kids Are Shunning Sweetened DrinksAs Disease Outbreaks Tied to 'Anti-Vaxxers' Rise, States Take Action'Don't Give Up:' Parents' Intuition Spots a Rare Illness Before Doctors DoFDA Approves First Contact Lens That Slows Myopia ProgressionStereotypes About Girls and Math Don't Add Up, Scans ShowStudies Confirm HPV Shot Is SafeThese Sports Are Most Likely to Send Young Americans to the ERNature Nurtures KidsClimate Change Will Hurt Kids Most, Report WarnsTough Childhoods Can Leave a Lifetime of Harm, Experts SayMany U.S. Parents Can't Find a Psychiatrist to Help Their ChildAnti-Vaxxers Find Ways Around States' 'Personal Exemption' BansMake a Plan for Gardening Next Spring With Your KidsCheck Those Halloween Treats So They're Safe to EatFast-Food Outlet in Neighborhood Could Mean Heavier Kids: StudyAntihistamines Linked to Delayed Care for Severe Allergic Reaction: StudyPain Twice as Common for Kids With Autism: StudyPediatricians' Group Calls for More Research on Artificial SweetenersExperts Support Weight-Loss Surgery for Very Obese KidsHalloween Can Be Frightful for Kids With Allergies, AsthmaLawn Mowers May Be Even More Dangerous for Rural KidsHow Young Is Too Young to Leave Kids Home Alone?Skiing, Snowboarding Injuries Most Severe Among Younger KidsKids' Trampoline Injuries Take Another Bounce Upwards
Questions and AnswersLinks
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

New Drug Combats Leading Cause of Dwarfism

HealthDay News
by -- Robert Preidt
Updated: Jun 21st 2019

new article illustration

FRIDAY, June 21, 2019 (HealthDay News) -- An experimental drug increased growth rates in children with dwarfism, according to a new study.

The four-year phase 2 trial was conducted at centers in the United States, France, United Kingdom and Australia, and included 35 children, ages 5-14, with the genetic bone disorder achondroplasia, the most common type of dwarfism.

The children were divided into four groups that received daily injections of the drug vosoritide, which helps regulate bone development, in increasing amounts.

The average increase in height among the children was about 2.4 inches a year, which is close to growth rates among children of average stature, according to the study published June 18 in the New England Journal of Medicine.

On average, the children's growth rate increased by 50%, said the authors of the study, which was designed and funded by drug maker BioMarin Pharmaceutical, which also analyzed the data.

The side effects of the drug were mostly mild, according to the researchers.

Vosoritide is now being tested in a phase 3 trial in a larger group of patients ages 5-18.

Achondroplasia is caused by overactivity of a signal that stops growth, which can be compared to overwatering a plant, explained study lead author Ravi Savarirayan, a clinical geneticist at Murdoch Children's Research Institute in Melbourne, Australia.

"This drug basically kinks the hose so that the plant gets the right amount of water and can resume regular growth," Savarirayan said in an institute news release.

Achondroplasia, which affects about 1 in every 25,000 infants, is caused by a mutation in the FGFR3 gene that impairs the growth of bones in the limbs, the spine and base of the skull.

Common complications among children with achondroplasia include spinal cord compression, spinal curvature and bowed legs. About half require spinal or other surgery.

"This study is the very first report of a possible disruptive, precision therapy for children with achondroplasia, which we hope will improve their health outcomes and functioning, as well as increase their height and access to their environment," Savarirayan said.

More information

The U.S. National Library of Medicine has more on achondroplasia.